Primary Record
veratridine
- In stock
- 880 g
- Purity
- 99.6 %
- CAS
- 71-62-5
Compound Identifiers & Properties
- CAS
- 71-62-5
- PubChem CID
- 6280
- SMILES
- C[C@H]1CC[C@H]2[C@@]([C@]3([C@H](C[C@]4([C@@H]5CC[C@H]6[C@]7([C@]5(C[C@]4([C@@H]3CN2C1)O)O[C@@]6([C@H](CC7)OC(=O)C8=CC(=C(C=C8)OC)OC)O)C)O)O)O)(C)O
- Canonical SMILES
- COc1ccc(C(=O)O[C@H]2CC[C@@]3(C)[C@@H]4CC[C@H]5[C@]6(O)C[C@H](O)[C@@]7(O)[C@@H](CN8C[C@@H](C)CC[C@H]8[C@@]7(C)O)[C@]6(O)C[C@@]53O[C@]24O)cc1OC
Names & Synonyms
- veratridine
- veratrine
- 3-Veratroylveracevine
- veratridin
- Veratrine (amorphous)
- 3-Veratroylveracevin
- 71-62-5
- Veratrine[amorphous]
- M4BNP1KR7W
- Veratrin (Amorphous)
- UNII-M4BNP1KR7W
- Veratridine (Standard)
- Veratrine (amorphous) (VAN)
- VERATRIDINE [MI]
- RefChem:901792
- VERATRIDINE [HSDB]
- CHEBI:28051
- D0S4MN
- HSDB 4078
- AC1L1M6O
- SCHEMBL50074
- BSPBio_001515
- DTXSID2058467
- NIOSH/FL5630000
- NSC 7524
- EINECS 200-758-4
- NSC7524
- CHEMBL439496
- GTPL2626
- orb1987226
- NSC-7524
- HY-N6691R
- BRN 0078875
- CID6280
- FVECELJHCSPHKY-CJNDGLNJSA-N
- FVECELJHCSPHKY-YFUMOZOISA-N
- A1E26
- C36H51NO11
- DTXCID801768835
- GLXC-22140
- HMS1791L17
- HMS1989L17
- HMS3402L17
- KST-1A8023
- CID:6280
- HY-N6691
- MSK40017
- 1,2,4-triazolo[4,3-a]pyridin-3-ol
- AR-1A5048
- BBF-04109
- BDBM50214776
- HB1006
- ZINC65731559
- O3-(3,4-Dimethoxybenzoyl)veracevine
- AKOS024457334
- C36-H51-N-O11
- ACN-056795
- CCG-208285
- FV34892
- FL56300000
- NCGC00163144-03
- DA-58985
- MS-31063
- NCI60_041647
- SID:53788722
- J192.548B
- LS-162049
- CS-0029015
- 5-21-13-00709 (Beilstein Handbook Reference)
- G13895
- 4,9-Epoxycevane-3,4,12,14,16,17,20-heptol 3-(3,4-dimethoxybenzoate)
- D014701
- Q721202
- Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3beta,4alpha,16beta)-
- 4,9-Epoxycevane-3beta,4alpha,12,14,16beta,17,20-heptol 3-veratrate
- BRD-K60923938-001-02-8
- 4beta,12,14,16beta,17,20-hexahydroxy-4alpha,9-epoxycevan-3beta-yl 3,4-dimethoxybenzoate
- Cevane-3-beta,4-alpha,12,14,16-beta,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate)
- [(1R,2S,6S,9S,10R,11S,12S,14R,15S,18S,19S,22S,23S,25R)-1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] 3,4-dimethoxybenzoate
- 4,9-Epoxycevane-3-beta,4-beta,12,14,16-beta,17,20-heptol 3-veratrate
- (3|A,4|A,16|A)-4,12,14,16,17,20-hexahydroxy-4,9-epoxycevan-3-yl 3,4-dimethoxybenzoate
- Cevane-3-beta,4-beta,12,14,16-beta,17,20-heptol, 4,9-epoxy-, 3-veratrate
- 4,9-epoxycevan-3beta,4alpha,12,14,16beta,17,20-heptol-3-veratrumat
- 4?,9-Epoxy-3?-veratroyloxy-5?-cevan-4?,12,14,16?,17,20-hexaol
- 74388-74-2
- 4alpha,9-Epoxycevane-3beta,4,12,14,16beta,17,20-heptol 3-(3,4-dimethoxybenzoate)
- (1R,10R,11S,12S,14R,23S,25R)-1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo(12.12.0.02,11.04,9.015,25.018,23.019,25)hexacosan-22-yl 3,4-dimethoxybenzoate
- (1R,2S,6S,9S,10R,11S,12S,14R,15S,18S,19S,22S,23S,25R)-1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl 3,4-dimethoxybenzoate
- (3-beta,4-alpha,16-beta)-4,9-Epoxycevane-3,4,12,14,16,17,20-heptol 3-(3,4-dimethoxybenzoate)
- (3.BETA.,4.ALPHA.,16.BETA.)-4,9-EPOXYCEVANE-3,4,12,14,16,17,20-HEPTOL 3-(3,4-DIMETHOXYBENZOATE)
- (3.BETA.,4.BETA.,16.BETA.)-4,12,14,16,17,20-HEXAHYDROXY-4,9-EPOXYCEVAN-3YL 3,4-DIMETHOXYBENZOATE
- (3S,4S,4aS,6aS,6bR,8S,8aS,9R,9aS,12S,15aS,15bR,16aR,16bS)-4,6b,8,8a,9,15b-hexahydroxy-9,12,16b-trimethyldocosahydro-1H-4,16a-epoxybenzo[4,5]indeno[1,2-h]pyrido[1,2-b]isoquinolin-3-yl 3,4-dimethoxybenzoate
- 200-758-4
- Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3.beta.,4.alpha.,16.beta.)-
- Cevane-3,4,12,14,16,17,20-heptol, 4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3ss,4a,16ss)-; Veratridine (6CI,7CI,8CI); 3-Veratroylveracevine; NSC 7524; Veracevine, veratrate
- Cevane-3,4,12,14,16,17,20-heptol,4,9-epoxy-, 3-(3,4-dimethoxybenzoate), (3b,4a,16b)-